Abstract:First-Line Treatments (Table 8.1)
CarbamazepineCarbamazepine was initially shown to be more effective than a placebo for treating trigeminal neuralgia in a randomized placebo-controlled trial published in 1966 [1]. At that time, doses from 100 mg three times per day to 200 mg four times per day were used. Patients using carbamazepine for 2 weeks had a 58% improvement in pain when compared to a 26% improvement in the placebo group, which was statistically significant. Carbamazepine also decreased the number of … Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.